Basal cell carcinoma of the face is a common problem facing the surgeon being the most common human cancer accounting for approximately 75% of nonmelanoma skin cancers and almost one-fourth of all body cancers and the area concerned is the commonest region to be affected. In our study, we evaluate different reconstructive modalities in surgical treatment of basal cell carcinoma of the face.